Skip to main content

Table 4 Clinical outcome

From: Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: A prospective observational study

 

LNi-

LNi+

 

BMi-

BMi+

 

Time, months

56.5

55.5

ns

55.9

56.9

ns

Disease free

      

   no

6 (6%)

2 (2%)

 

5 (5%)

3 (3%)

 

   yes

69 (66%)

27 (26%)

ns

76 (73%)

20 (19%)

ns

Overall survival

      

   died

3 (3%)

1 (1%)

 

2 (2%)

2 (2%)

 

   alive

72 (69%)

28 (27%)

ns

79 (76%)

21 (20%)

ns

  1. Abbreviations: BMi, bone marrow involvement; LNi, lymph node involvement; ns, nonsignificant
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us